Home
Polar Capital Holdings reported a 8.47% stake in Enliven Therapeutics ELVN · 59,800,406 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 8.47%
- Last report
- 5.17% · filed 25/08/14
- Shares held
- 59,800,406 sh
- Class
- Common Stock, $0.001 par value per share
- Holder
- Polar Capital Holdings
- Event date
- 26/03/31
- Filed
- 26/05/15
8.47% stake · +3.3pp from the last report
- Stake
- 8.47%
- Last report
- 5.17%
- Since last report
- +3.3pp
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Polar Capital Holdings's other 5% stake reports
- Polar Capital Holdings
5% stakeArcutis Biotherapeutics
5% stakeArcutis Biotherapeutics
ARQT
5.28% stake
6,606,945 sh
5.28% stake
Filed 08/14
- Polar Capital Holdings
5% stakeVerastem
5% stakeVerastem
VSTM
4.8% stake
3,700,000 sh
4.8% stake
Filed 07/08
- Polar Capital Holdings
5% stakeVerastem
5% stakeVerastem
VSTM
5.09% stake
3,398,898.71 sh
5.09% stake
Filed 01/05
- Polar Capital Holdings
5% stakeHagerty
5% stakeHagerty
HGTY
5.85% stake
5,306,865 sh
5.85% stake
Filed 25/09/04
- Polar Capital Holdings
5% stakeArcutis Biotherapeutics
5% stakeArcutis Biotherapeutics
ARQT
4.2% stake
5,006,472 sh
4.2% stake
Filed 25/08/14
